Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Helius Medical Technologies Inc (NQ: HSDT )

0.2355 +0.0055 (+2.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 148,232
Open 0.2310
Bid (Size) 0.2300 (41)
Ask (Size) 0.2400 (6)
Prev. Close 0.2300
Today's Range 0.2250 - 0.2450
52wk Range 0.2000 - 3.865
Shares Outstanding 28,211,362
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Helius Medical Tech's Return On Capital Employed Insights
 
Via Benzinga
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
From Helius Medical Technologies, Inc.
Via Globe NewsWire

Performance

YTD
-26.41%
-26.41%
1 Month
-18.48%
-18.48%
3 Month
-6.21%
-6.21%
6 Month
-50.31%
-50.31%
1 Year
-92.91%
-92.91%

More News

Read More
Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from Stroke
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Earnings Preview For Helius Medical Tech
Via Benzinga
Looking Into Helius Medical Tech's Return On Capital Employed
Via Benzinga
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket
Via Benzinga
Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results
From Helius Medical Technologies, Inc.
Via Globe NewsWire
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.